The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients

被引:26
作者
Georgiev, Kaloyan D. [1 ]
Hvarchanova, Nadezhda [2 ]
Georgieva, Marieta [2 ]
Kanazirev, Branimir [3 ]
机构
[1] Med Univ Prof Dr Paraskev Stoyanov, Fac Pharm, Dept Pharmaceut Technol, Varna, Bulgaria
[2] Med Univ Prof Dr Paraskev Stoyanov, Fac Pharm, Dept Pharmacol Toxicol & Pharmacotherapy, Varna, Bulgaria
[3] Med Univ Prof Dr Paraskev Stoyanov, Fac Med, UMHAT St Marina, Dept Internal Med, Varna, Bulgaria
关键词
Bulgaria; Clinical pharmacist; Drug-drug interactions; Heart failure; Polypharmacy; INTERVENTION; OUTCOMES; IMPACT; CARE;
D O I
10.1007/s11096-019-00918-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background The treatment of heart failure patients is very complex and includes lifestyle modification as well as different pharmacological therapies. Polypharmacy is very common in such patients and they are at increased risk of potential drug-drug interactions and associated effects such as poor adherence, compliance and adverse events. Objective The aim of the present study is to investigate retrospectively the prescribed pharmacotherapy of the hospital discharged heart failure patients for possible drug interactions. Settings Clinic for Cardiology of the "Saint Marina" University Hospital in Varna, Bulgaria. Method Lexicomp((R)) Drug interaction software was used for screening potential drug-drug interactions. Logistic regression was applied to determine the odds ratio for the association between the age and number of drugs taken and the number of potential drug-drug interactions. Main outcome measure Incidence and type of pDDIs in geriatric heart failure patients. Results A retrospective study was conducted by reviewing the medical records of 248 selected heart failure patients for the prescribed medicines for a 1-year period (January 2015-December 2015). The total number of potential drug-drug interactions was 1532, or approximately 6.28 (+/- 4.72 SD) per one person. The range of prescribed drugs was between three and fourteen, 92% of them have been taking more than five medicines, an average of 7.12 (+/- 2.07 SD) per patient. The average age was 72.35 (+/- 10.16 SD). The results have shown stronger association between the number of drugs taken (more than 7) and the occurrence of potential drug-drug interactions (more than 10)-37.84 (95% CI 9.012-158.896, P <= 0.001). No statistically significant differences were found between age and occurrence of potential drug-drug interactions (more than 10)-1.008 (95% CI 0.441-2.308, P=0.848). Conclusion The incidence of drug-drug interactions in heart failure patients is high. The clinical pharmacist, as a part of the multidisciplinary team, could reduce medication-related problems, such as drug interactions, and to optimize drug therapy by checking the treatment prescribed at the discharge of these patients.
引用
收藏
页码:1555 / 1561
页数:7
相关论文
共 23 条
  • [1] A Review of the Role of the Pharmacist in Heart Failure Transition of Care
    Anderson, Sarah L.
    Marrs, Joel C.
    [J]. ADVANCES IN THERAPY, 2018, 35 (03) : 311 - 323
  • [2] Improved quality in the hospital discharge summary reduces medication errors-LIMM: Landskrona Integrated Medicines Management
    Bergkvist, Anna
    Midlov, Patrik
    Hoglund, Peter
    Larsson, Lisa
    Bondesson, Asa
    Eriksson, Tommy
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (10) : 1037 - 1046
  • [3] Assessing the Quality and Comparative Effectiveness of Team-Based Care for Heart Failure Who, What, Where, When, and How
    Cooper, Lauren B.
    Hernandez, Adrian F.
    [J]. HEART FAILURE CLINICS, 2015, 11 (03) : 499 - +
  • [4] Pharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people's lives in the context of health care trends, evidence and policies
    Dolovich, Lisa
    Austin, Zubin
    Waite, Nancy
    Chang, Feng
    Farrell, Barbara
    Grindrod, Kelly
    Houle, Sherilyn
    McCarthy, Lisa
    MacCallum, Lori
    Sproule, Beth
    [J]. CANADIAN PHARMACISTS JOURNAL, 2019, 152 (01) : 45 - 53
  • [5] Adverse Drug Reactions in Patients with Cardiovascular Disease
    Faulx, Michael D.
    Francis, Gary S.
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2008, 33 (12) : 703 - 768
  • [6] Impact of clinical pharmacists in outpatient oncology practices: A review
    Gatwood, Justin
    Gatwood, Katie
    Gabre, Ezra
    Alexander, Maurice
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (19) : 1549 - 1557
  • [7] Medication Reviews by Clinical Pharmacists at Hospitals Lead to Improved Patient Outcomes: A Systematic Review
    Graabaek, Trine
    Kjeldsen, Juel
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (06) : 359 - 373
  • [8] Impact of early in-hospital medication review by clinical pharmacists on health services utilization
    Hohl, Corinne M.
    Partovi, Nilu
    Ghement, Isabella
    Wickham, Maeve E.
    McGrail, Kimberlyn
    Reddekopp, Lisa N.
    Sobolev, Boris
    [J]. PLOS ONE, 2017, 12 (02):
  • [9] Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan
    Ismail, Mohammad
    Iqbal, Zafar
    Khattak, Muhammad Bilal
    Khan, Muhammad Imran
    Arsalan, Hassan
    Javaid, Arshad
    Gul, Qamar
    Khan, Faramoz
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (03) : 455 - 462
  • [10] Kalisch LM, 2010, FUTUR CARDIOL, V6, P255, DOI [10.2217/fca.09.67, 10.2217/FCA.09.67]